1Stanford Cancer Institute.
2UCSF Helen Diller Family Comprehensive Cancer Center.
J Natl Compr Canc Netw. 2020 Jun;18(6):755-781. doi: 10.6004/jnccn.2020.0026.
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.
NCCN 临床实践指南在肿瘤学中为霍奇金淋巴瘤 (HL) 提供了成人 HL 患者管理的建议。NCCN 小组至少每年开会一次，以审查其机构内评审员的意见，检查相关数据，并重新评估和更新他们的建议。目前对经典 HL 的治疗涉及单独化疗或联合治疗方式的初始治疗，然后进行 PET/CT 分期以评估治疗反应。总体而言，毒性更小、更有效的方案的引入极大地提高了 HL 的治愈率。NCCN 指南的这一部分重点关注经典 HL 的管理。
